SCHEMBL4300957

SCHEMBL4300957

CN(C)c1ccnc(-c2cc(O)cc(CO)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
PTGS1 P23219 4/20 0.36
TSHR P16473 1/20 0.34
PTGS2 P35354 3/20 0.34
NQO2 P16083 1/20 0.34
SIRT2 Q8IXJ6 2/20 0.32
SYK P43405 3/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
APP P05067 2/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
CHRM1 P11229 1/20 0.32
ADRA1D P25100 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
GRIN1 Q05586 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4313244 0.90 KDM4E (0.41) ALDH1A1KDM4ESIRT2SYKABL1
SCHEMBL4309068 0.87 ALDH1A1 (0.38) ALDH1A1KDM4EPTGS1TSHRPTGS2
SCHEMBL4303630 0.84 ALDH1A1 (0.35) ALDH1A1KDM4EPTGS1TSHRSIRT2
SCHEMBL4315323 0.79 MAP4K4 (0.31) ALDH1A1KDM4ESIRT2
SCHEMBL4310126 0.78 CCR1 (0.38) ALDH1A1SYKSRCCDK2ZAP70
SCHEMBL4308839 0.76 EIF4E (0.34) ALDH1A1KDM4ESIRT2
SCHEMBL196641 0.76 ALDH1A1 (0.53) ALDH1A1KDM4ETSHRSIRT2ABL1
SCHEMBL13985851 0.75 MAP4K4 (0.39) ALDH1A1KDM4ESYKAPPNPC1
SCHEMBL4316270 0.75 KDM4E (0.32) KDM4ESIRT2GRIN2DGRIN3BCHRM1
SCHEMBL4311559 0.75 KDM4E (0.38) ALDH1A1KDM4ESIRT2SYKABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090044345-A1 Use of Metal Complex Compounds as Oxidation Catalysts CIBA CORP. 2009-02-19 US disclosed
US-20090044345-A1 Use of Metal Complex Compounds as Oxidation Catalysts CIBA CORP. 2009-02-19 US disclosed
US-20090044345-A1 Use of Metal Complex Compounds as Oxidation Catalysts CIBA CORP. 2009-02-19 US disclosed
EP-1981635-A1 USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS Ciba Holding Inc. (CH) 2008-10-22 EP disclosed
WO-2007090461-A1 USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS CIBA HOLDING INC. (CH) 2007-08-16 WO disclosed
WO-2007090461-A1 USE OF METAL COMPLEX COMPOUNDS AS OXIDATION CATALYSTS CIBA HOLDING INC. (CH) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090044345-A1 Use of Metal Complex Compounds as Oxidation Catalysts MT-CO2, MT-CO1, SOD1 ALDH1A1 984/4885KDM4E 3219/4885PTGS1 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.